DICE Annual EBITDA
-$80.78 M
-$32.66 M-67.87%
31 December 2022
Summary:
As of February 5, 2025, DICE annual earnings before interest, taxes, depreciation & amortization is -$80.78 million, with the most recent change of -$32.66 million (-67.87%) on December 31, 2022. During the last 3 years, it has fallen by -$68.58 million (-561.85%).DICE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DICE Quarterly EBITDA
-$34.13 M
-$9.11 M-36.43%
30 June 2023
Summary:
As of February 5, 2025, DICE quarterly earnings before interest, taxes, depreciation & amortization is -$34.13 million, with the most recent change of -$9.11 million (-36.43%) on June 30, 2023. Over the past year, it has dropped by -$13.37 million (-64.42%).DICE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DICE TTM EBITDA
-$101.16 M
-$13.37 M-15.23%
30 June 2023
Summary:
As of February 5, 2025, DICE TTM earnings before interest, taxes, depreciation & amortization is -$101.16 million, with the most recent change of -$13.37 million (-15.23%) on June 30, 2023. Over the past year, it has dropped by -$29.28 million (-40.74%).DICE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DICE EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -67.9% | -64.4% | -40.7% |
| 3 y3 years | -561.9% | -484.0% | -1631.0% |
| 5 y5 years | -561.9% | -484.0% | -1631.0% |
DICE EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +561.8% | +484.0% | +1631.0% |
DICE Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$34.13 M(+36.4%) | -$101.16 M(+15.2%) |
| Mar 2023 | - | -$25.02 M(+13.0%) | -$87.79 M(+8.7%) |
| Dec 2022 | -$80.78 M(+67.9%) | -$22.14 M(+11.4%) | -$80.78 M(+8.3%) |
| Sept 2022 | - | -$19.87 M(-4.3%) | -$74.62 M(+3.8%) |
| June 2022 | - | -$20.76 M(+15.2%) | -$71.88 M(+23.4%) |
| Mar 2022 | - | -$18.01 M(+12.7%) | -$58.25 M(+21.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$48.12 M(+109.0%) | -$15.98 M(-6.7%) | -$48.12 M(+23.1%) |
| Sept 2021 | - | -$17.13 M(+140.2%) | -$39.10 M(+40.6%) |
| June 2021 | - | -$7.13 M(-9.5%) | -$27.82 M(+34.5%) |
| Mar 2021 | - | -$7.88 M(+13.3%) | -$20.68 M(+61.6%) |
| Dec 2020 | -$23.03 M(+88.7%) | -$6.96 M(+19.0%) | -$12.80 M(+119.0%) |
| Sept 2020 | - | -$5.84 M | -$5.84 M |
| Dec 2019 | -$12.21 M | - | - |
FAQ
- What is DICE Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for DICE Therapeutics?
- What is DICE Therapeutics annual EBITDA year-on-year change?
- What is DICE Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for DICE Therapeutics?
- What is DICE Therapeutics quarterly EBITDA year-on-year change?
- What is DICE Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for DICE Therapeutics?
- What is DICE Therapeutics TTM EBITDA year-on-year change?
What is DICE Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of DICE is -$80.78 M
What is the all time high annual EBITDA for DICE Therapeutics?
DICE Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$12.21 M
What is DICE Therapeutics annual EBITDA year-on-year change?
Over the past year, DICE annual earnings before interest, taxes, depreciation & amortization has changed by -$32.66 M (-67.87%)
What is DICE Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of DICE is -$34.13 M
What is the all time high quarterly EBITDA for DICE Therapeutics?
DICE Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$5.84 M
What is DICE Therapeutics quarterly EBITDA year-on-year change?
Over the past year, DICE quarterly earnings before interest, taxes, depreciation & amortization has changed by -$13.37 M (-64.42%)
What is DICE Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of DICE is -$101.16 M
What is the all time high TTM EBITDA for DICE Therapeutics?
DICE Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$5.84 M
What is DICE Therapeutics TTM EBITDA year-on-year change?
Over the past year, DICE TTM earnings before interest, taxes, depreciation & amortization has changed by -$29.28 M (-40.74%)